Conference abstract · 23 Jun 2025
Conference abstractPublished 20 Aug 2012
Molecular signatures of Venezuelan equine encephalitis in mice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Venezuelan equine encephalitis virus (VEEV) is an emerging infectious agent and a CDC category B priority pathogen. VEEV has caused periodic outbreaks involving several hundred thousands of equine and human cases. VEEV may also cause severe to fatal encephalitic disease in young and old subjects with underdeveloped or weak immune system. Inflammation in brain following VEEV infection is multifocal and believed to play a key role in the pathogenesis of VEEV. However, the underlying molecular mechanisms of VEEV encephalitis are poorly understood. Molecular characterization of VEEV encephalitis and its kinetics were evaluated by gene expression profiling of VEEV infected mice brain using whole genome and pathway specific toll-like receptors (TLR) and extracellular matrix and adhesion molecule gene microarrays. Localized expression of translation products was evaluated by immunohistochemistry in the brain tissues. VEEV infection of mice brain resulted in the differential modulation of several immune pathways such as antigen presentation, inflammation, apoptosis and response to virus. Specifically, VEEV infection up regulated Toll like receptor signaling pathways components and revealed a MyD88 biased TLR signaling. Comparative host gene expression analysis of mice infected with either neuroinvasive or non-neuroinvasive strains of VEEV identified signaling pathways specific to neurovirulent VEEV infection. A gene expression signature that was common to both the neuroinvasive and non-neuroinvasive strain of VEEV was also identified. Cell to cell adhesion molecules and extracellular matrix protein genes such as ICAM-1, VCAM-1 and MMPs were also differentially regulated in the mouse brain after VEEV infection. Studies in ICAM1 knockout mice infected with VEEV demonstrated a delay in initiation of disease accompanied with reduced inflammation in the brain early in the infection. A twenty percent reduction in the mortality following VEEV infection was also observed in ICAM-1 knockout mice. Studies were supported by a grant from DTRA, project number 4.10019_07_US_B. The opinions expressed in this abstract are those of the authors and do not reflect the views of the USUHS or the FDA.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Antivirals & Antiretrovirals.
Conference abstract · 23 Jun 2025
Exploring signature proteins to design a novel multi-epitope vaccine candidate against Mycobacterium tuberculosis: An in-silico approach
Conference abstract · 23 Jun 2025
Correlation Between the Rh/ABO system and infection due to sars cov2 in morocco
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Anuj Sharma”
- BylineArticles whose byline prints “Paridhi Gupta”
- BylineArticles whose byline prints “Manish Bhomia”
- BylineArticles whose byline prints “Shelley Honnold”
- BylineArticles whose byline prints “Bhaskar Bhattacharya”
- BylineArticles whose byline prints “Jing Han”
- BylineArticles whose byline prints “Raj K Puri”
- BylineArticles whose byline prints “Radha K Maheshwari”
